Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.77 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.77 |
| ▸ | TSHR | P16473 | 2/20 | 0.77 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | IKBKB | O14920 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.49 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8954009 | 0.91 | CYP3A4 (0.94) | TDP1ALDH1A1CYP3A4TSHRHSD17B10 | |
| Orthotolidine SCHEMBL8061312 | 0.89 | TDP1 (0.74) | TDP1ALDH1A1CYP3A4TSHRHSD17B10 | |
| Orthotolidine SCHEMBL49414 | 0.88 | CYP3A4 (1.00) | TDP1ALDH1A1CYP3A4TSHRHSD17B10 | |
| Orthotolidine SCHEMBL29386552 | 0.88 | CYP3A4 (1.00) | TDP1ALDH1A1CYP3A4TSHRHSD17B10 | |
| Orthotolidine SCHEMBL29365329 | 0.88 | CYP3A4 (1.00) | TDP1ALDH1A1CYP3A4TSHRHSD17B10 | |
| Orthotolidine SCHEMBL11207210 | 0.87 | TDP1 (0.71) | TDP1ALDH1A1CYP3A4TSHRHSD17B10 | |
| Orthotolidine SCHEMBL7683641 | 0.86 | CYP3A4 (0.77) | TDP1ALDH1A1CYP3A4TSHRHSD17B10 | |
| Orthotolidine SCHEMBL11189493 | 0.85 | CYP3A4 (0.94) | TDP1ALDH1A1CYP3A4TSHRHSD17B10 | |
| Orthotolidine SCHEMBL2812115 | 0.85 | CYP3A4 (0.94) | TDP1ALDH1A1CYP3A4TSHRHSD17B10 | |
| Orthotolidine SCHEMBL20547383 | 0.85 | CYP3A4 (0.94) | TDP1ALDH1A1CYP3A4TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025100475-A1 | COMPOSITION FOR IMAGE RECORDING AND METHOD FOR PRODUCING SAME | キヤノン株式会社 | 2025-05-15 | — | — | WO | disclosed |
| CN-113620816-B | Aromatic amine derivative organic electroluminescent material and device thereof | 北京夏禾科技有限公司 | 2025-01-10 | — | — | CN | disclosed |
| WO-2024144176-A1 | COMPOSITION FOR OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY APPARATUS | 삼성에스디아이 주식회사 | 2024-07-04 | — | — | WO | disclosed |
| CN-118250904-A | Method for manufacturing circuit board | 味之素株式会社 | 2024-06-25 | — | — | CN | disclosed |
| CN-111560171-B | Resin composition | 味之素株式会社 | 2024-06-18 | — | — | CN | disclosed |
| CN-118063932-A | Resin composition | 味之素株式会社 | 2024-05-24 | — | — | CN | disclosed |
| CN-111548625-B | Resin composition | 味之素株式会社 | 2024-04-05 | — | — | CN | disclosed |
| CN-111138856-B | Resin composition | 味之素株式会社 | 2024-01-23 | — | — | CN | disclosed |
| EP-4306612-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | Samsung Electronics Co., Ltd. (KR) | 2024-01-17 | — | — | EP | disclosed |
| CN-117043991-A | Polyimide compound, negative electrode material for lithium ion secondary battery using same, negative electrode for lithium ion secondary battery, and lithium ion secondary battery | 胜高科技股份有限公司 | 2023-11-10 | — | — | CN | disclosed |
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-1914221-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
| CN-1937994-A | Keratin dyeing compounds, keratin dyeing compositions containing them and their use | PROCTER & GAMBLE (US) | 2007-03-28 | — | — | CN | disclosed |
| EP-1753428-A2 | KINASE INHIBITORS AS THERAPEUTIC AGENTS | Abbott Laboratories (US) | 2007-02-21 | — | — | EP | disclosed |
| US-20060074102-A1 | Kinase inhibitors as therapeutic agents | ABBOTT LABORATORIES | 2006-04-06 | — | — | US | disclosed |
| WO-2005110410-A2 | KINASE INHIBITORS AS THERAPEUTIC AGENTS | ABBOTT LABORATORIES (US) | 2005-11-24 | — | — | WO | disclosed |
| US-6242115-B1 | ELECTROLUMINESCENCE | THE UNIVERSITY OF SOUTHERN CALIFORNIA | 2001-06-05 | — | — | US | disclosed |
| WO-1999013691-A1 | OLEDS CONTAINING THERMALLY STABLE ASYMMETRIC CHARGE CARRIER MATERIALS | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 1999-03-18 | — | — | WO | disclosed |
| US-4670566-A | ANTIIFLAMMATORY AGENTS, ANTICOAGULANTS | A. H. ROBINS COMPANY, INCORPORATED (US) | 1987-06-02 | — | — | US | disclosed |
| US-4440785-A | Methods of using 2-aminobiphenylacetic acids, esters, and metal salts thereof to treat inflammation | A. H. ROBINS COMPANY, INC. (US) | 1984-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060074102-A1 | Kinase inhibitors as therapeutic agents | ABL1, MAP3K19, MAP3K20 | TDP1 1395/4885ALDH1A1 2415/4885CYP3A4 2782/4885 |
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | NISCH, BLVRB, BBOX1 | TDP1 4196/4885ALDH1A1 4339/4885CYP3A4 177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.